ClinicalTrials.Veeva

Menu

A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy

Seoul National University logo

Seoul National University

Status and phase

Unknown
Phase 4

Conditions

Misadventure During Aspirating Needle Biopsy
Infection
Prostatic Diseases

Treatments

Drug: Povidone-Iodine

Study type

Interventional

Funder types

Other

Identifiers

NCT02245334
B-1403/243-004

Details and patient eligibility

About

To assess the effect of povidone-iodine on infectious complication rate caused by transrectal prostate biopsy

Full description

the effect of povidone-iodine on infectious complication rate caused by transrectal prostate biopsy

Enrollment

1,578 estimated patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • who undergo transrectal prostate biopsy

Exclusion criteria

  • patients who refuse to be included, patients who have hypersensitivity to iodine, patients who have abnormal thyroid function, patients who do not visit follow-up, patients who have received prior radioactive-iodine therapy

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

1,578 participants in 2 patient groups

Povidone-iodine
Experimental group
Description:
povidone iodine pill
Treatment:
Drug: Povidone-Iodine
no intervention
No Intervention group
Description:
no intervention

Trial contacts and locations

1

Loading...

Central trial contact

Sangchul Lee

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems